标题
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 21, Issue 6, Pages R445-R460
出版商
Bioscientifica
发表日期
2014-10-09
DOI
10.1530/erc-14-0106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epithelial-Mesenchymal Transition Markers in the Differential Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors
- (2013) Jose A. Galván et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
- (2013) H K Ahn et al. BRITISH JOURNAL OF CANCER
- An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
- (2013) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study
- (2013) Edward M. Wolin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Neuroendocrine tumours: cracking the epigenetic code
- (2013) A Karpathakis et al. ENDOCRINE-RELATED CANCER
- Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
- (2013) Daniel Castellano et al. EUROPEAN JOURNAL OF CANCER
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- The genomic landscape of small intestine neuroendocrine tumors
- (2013) Michaela S. Banck et al. JOURNAL OF CLINICAL INVESTIGATION
- Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids
- (2013) Valeria Giandomenico et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors
- (2013) Catharina Larsson NEUROENDOCRINOLOGY
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Uncovering the mechanisms that regulate tumor-induced T-cell anergy
- (2013) Brian T. Abe et al. OncoImmunology
- Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A
- (2012) R. Fossmark et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phosphorylation of sst2 Receptors in Neuroendocrine Tumors after Octreotide Treatment of Patients
- (2012) Beatrice Waser et al. AMERICAN JOURNAL OF PATHOLOGY
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
- (2012) Shinichi Yachida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
- (2012) Thomas Tawadros et al. ENDOCRINE-RELATED CANCER
- Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
- (2012) Anna Koumarianou et al. ENDOCRINE-RELATED CANCER
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas
- (2012) Tao Cui et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Targeting Mutant p53 in Human Tumors
- (2012) Brian D. Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Secretin Receptor Promotes the Proliferation of Endocrine Tumor Cells Via the PI3K/AKT Pathway
- (2012) Misu Lee et al. MOLECULAR ENDOCRINOLOGY
- Diffuse Endocrine System, Neuroendocrine Tumors and Immunity: Whats New?
- (2012) Pietro Ameri et al. NEUROENDOCRINOLOGY
- Virotherapy of Neuroendocrine Tumors
- (2012) Magnus Essand NEUROENDOCRINOLOGY
- Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications
- (2012) Jean-Yves Scoazec NEUROENDOCRINOLOGY
- Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors
- (2012) Marianne Pavel NEUROENDOCRINOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer and Telomeres--An ALTernative to Telomerase
- (2012) J. W. Shay et al. SCIENCE
- Profiling mTOR pathway in neuroendocrine tumors
- (2012) S. Cingarlini et al. Targeted Oncology
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interleukin 1β Gene Single-Nucleotide Polymorphisms and Susceptibility to Pancreatic Neuroendocrine Tumors
- (2011) Maja Cigrovski Berković et al. DNA AND CELL BIOLOGY
- Somatostatin and Dopamine Receptor Profile of Gastroenteropancreatic Neuroendocrine Tumors: An Immunohistochemical Study
- (2011) Evanthia Diakatou et al. ENDOCRINE PATHOLOGY
- The role of somatostatin and dopamine D2 receptors in endocrine tumors
- (2011) Federico Gatto et al. ENDOCRINE-RELATED CANCER
- Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells
- (2011) Alessia Di Florio et al. ENDOCRINE-RELATED CANCER
- Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
- (2011) Puja Gaur et al. GASTROENTEROLOGY
- Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells
- (2011) J Leja et al. GENE THERAPY
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
- (2011) John K Ramage et al. GUT
- Loss of PTEN Expression in Neuroendocrine Pancreatic Tumors
- (2011) M. Krausch et al. HORMONE AND METABOLIC RESEARCH
- Oncolytic Viruses for the Treatment of Neuroendocrine Tumors
- (2011) M. Essand et al. HORMONE AND METABOLIC RESEARCH
- Everolimus is an active agent in medullary thyroid cancer: a clinical andin vitrostudy
- (2011) A. Faggiano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glucose-Dependent Insulinotropic Polypeptide Receptors in Most Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
- (2011) Beatrice Waser et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy
- (2011) Corinne Bousquet et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors
- (2011) Claire Sanchez et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Mechanisms of mTOR inhibitor resistance in cancer therapy
- (2011) Jennifer S. Carew et al. Targeted Oncology
- The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment
- (2010) Bernhard Svejda et al. CANCER
- High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors
- (2010) Erika Grossrubatscher et al. CANCER BIOLOGY & THERAPY
- A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors
- (2010) Matthew H. Kulke et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Compensatory activation of Akt in response to mTOR and Raf inhibitors – A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
- (2010) Kathrin Zitzmann et al. CANCER LETTERS
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
- (2010) K. M. Detjen et al. CLINICAL CANCER RESEARCH
- The mTOR Pathway: A New Target in Cancer Therapy
- (2010) L. Ciuffreda et al. CURRENT CANCER DRUG TARGETS
- Hypoxia stimulates CXCR4 signalling in ileal carcinoids
- (2010) Yvonne Arvidsson et al. ENDOCRINE-RELATED CANCER
- The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors
- (2010) Nicté Figueroa-Vega et al. ENDOCRINE-RELATED CANCER
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors
- (2010) Md. Mustafizur Rahman et al. HUMAN PATHOLOGY
- A phase I study of temsirolimus and metformin in advanced solid tumours
- (2010) Mary J. MacKenzie et al. INVESTIGATIONAL NEW DRUGS
- Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 - clinical implications
- (2010) Mehtap Cakir et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 - molecular pathways
- (2010) Mehtap Cakir et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
- (2010) T. Binderup et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
- (2010) Jonathan Strosberg WORLD JOURNAL OF GASTROENTEROLOGY
- Pathogenesis of adrenocortical cancer
- (2009) Jérôme Bertherat et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- NFKB1 –94 Insertion/Deletion ATTG Polymorphism in Gastroenteropancreatic Neuroendocrine Tumors
- (2009) Ferda Sevimli Burnik et al. CHEMOTHERAPY
- Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis
- (2009) R Srirajaskanthan et al. ENDOCRINE-RELATED CANCER
- Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression
- (2009) Emelyne Dejeux et al. ENDOCRINE-RELATED CANCER
- Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
- (2009) Alida C. Fröberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers
- (2009) Natalie Jeffery et al. HISTOPATHOLOGY
- Clinical Implications of Microsatellite Instability andMLH1Gene Inactivation in Sporadic Insulinomas
- (2009) Mei Mei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
- (2009) Emanuel Christ et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors
- (2008) Christian N. Arnold et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning
- (2007) Mario Durán-Prado et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started